Tungsten West PLC

Tungsten West operates with a highly leveraged capital structure, as evidenced by a debt-to-equity ratio of -51.19, indicating that liabilities significantly exceed equity. The company's liquidity position is weak, with a current ratio of 0.11, suggesting limited ability to meet short-term obligations. The negative net income of £21.9 million and operating cash flow of -£8.1 million further underscore the company's financial stress.

Profitability metrics are deeply negative, with a net loss of £21.9 million and an operating loss of £15.9 million. The return on assets is -0.64%, indicating that the company is not generating returns from its asset base. The return on equity, while technically positive at 42.1%, is misleading due to the negative equity position. These figures fall well below the industry median for profitability and returns, highlighting significant underperformance relative to peers.

The company's revenue is reported as £0, and there is no disclosed segment or geographic breakdown in the provided data. This lack of transparency makes it difficult to assess the concentration of risk or the contribution of different regions or product lines to the company's financial performance.

Looking ahead, the company is expected to see a significant increase in revenue, with a mean estimate of £3.2 million for the current fiscal year. However, this is a substantial improvement from a base of zero, and the mean EBIT estimate of £1.1 million suggests a potential path to profitability. The capital expenditure of -£20,640 indicates minimal investment in new projects, which may limit future growth.

The risk assessment highlights medium liquidity risk and low dilution risk. The company's negative net cash position after subtracting total debt is a key flag. The dilution potential is low, and no significant adjustments have been applied to the valuation metrics. The risk of further dilution remains low, but the company's financial position is fragile, and any additional capital raising could impact shareholder value.

Recent events and filings indicate that the company is under pressure to improve its financial performance. The analyst estimates suggest a consensus view of potential recovery, with a mean price target of £62.20. However, the company's current financial position and lack of revenue make these estimates speculative.